Top in cardiology: AI tool for predicting CVD risk; unregulated heart failure therapies
Click Here to Manage Email Alerts
A deep-learning model may help physicians predict atherosclerotic CVD risk in patients, according to data presented at the Radiological Society of North America annual meeting.
“The whole idea with this research is that there is additional information on the images about someone’s future risk for cancer or heart disease that we do not see as radiologists, or perhaps see but don’t know how to categorize it,” study co-author Michael T. Lu, MD, MPH, co-director of the Massachusetts General Hospital Cardiovascular Imaging Research Center, told Healio. “The idea was to use existing trial data, feed it into an [artificial intelligence] algorithm along with what happens to a person 6 to 12 years later, and teach that tool to predict which patients go on to have a heart attack or stroke.”
A review of data on the validity of the AI tool was the top story in cardiology last week.
Another top story was about a new statement from the American Heart Association on the risks and benefits of complementary and alternative therapies for heart failure, which could worsen symptoms and interact with prescribed medications.
Read these and more top stories in cardiology below:
Single chest X-ray can predict ASCVD risk, determine statin eligibility
A deep-learning model using information from a single chest X-ray reliably predicted atherosclerotic CVD risk and statin eligibility when compared with a common risk calculator, researchers reported. Read more.
Alternative HF therapies could worsen symptoms, interact with prescribed medications
Complementary and alternative therapies for heart failure could potentially worsen symptoms and interact with prescribed medications, and clinicians and patients should be aware of a lack of federal regulation for such therapies, researchers wrote. Read more.
‘Nudges’ could increase appropriate statin prescription in primary care practice
Physician “nudges” via electronic health record prompts and peer comparison feedback improved statin prescription in the primary care setting for eligible patients compared with usual care, researchers reported. Read more.
Cardiometabolic benefits of micronutrient supplements vary
Supplementation of certain micronutrients benefited cardiometabolic health, but others did not, according to a systematic review and meta-analysis. Read more.
‘ZIP code matters’: COVID-19 hospitalizations, CV outcomes differ by where people live
Social and economic factors have the greatest impact on COVID-19 outcomes, including an “epidemic” of cardiovascular diseases and hospitalizations, and social determinants of health must be addressed to counter disparities, according to a speaker at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease. Read more.